<DOC>
	<DOCNO>NCT02165085</DOCNO>
	<brief_summary>The purpose study determine whether patient vascular Ehlers-Danlos syndrome present significant specific change arterial endothelial smooth muscular cell signalling/secretion , comparison match healthy volunteer patient spontaneous arterial dissection .</brief_summary>
	<brief_title>Biomarkers Vascular Ehlers-Danlos Syndrome</brief_title>
	<detailed_description>Vascular Ehlers-Danlos syndrome rare inherit disease confers exceptional organ fragility seamingly healthy young adult . The disease cause mutation COL3A1 gene encode type III collagen , critical ensure physical resistance mechanical stress hollow organ . The disease result increase tissular fragility , responsible spontaneous arterial rupture dissection spontaneous bowel perforation . The life-expectancy patient vascular Ehlers-Danlos syndrome reduce recur accident . The exact mechanism trigger arterial accident unknown . Recent finding suggest possible deleterious effect inflammation possible dysregulation TGF-beta pathway . Thus , purpose study identify alteration vascular endothelial smooth muscular cell signalling/secretion , confirm previously suggest mechanisms arterial accident vEDS patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ehlers-Danlos Syndrome</mesh_term>
	<criteria>Patients vascular EhlersDanlos syndrome must positively test pathogenic mutation within COL3A1 gene . In patient arterial dissection ( ) associate systemic arterial disease must rule , especially vascular EhersDanlos syndrome All subject must present chronic systemic disease , acute disease within seven day prior enrollment , diabetes mellitus arterial hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Ehlers-Danlos syndrome , vascular type</keyword>
	<keyword>Pathophysiology</keyword>
</DOC>